Manufacturing, Gene Therapies

Emmes Launches Cell and Gene Therapy Center

December 14, 2022

Emmes’ new facility is designed to support clients conducting cell and gene therapy research worldwide.

CSafe and BioLife Solutions Partnership Will Expand Supply Chain for Cell and Gene Therapies

October 28, 2022

The newly formed partnership between CSafe and BioLife will expand cold chain supply chain solutions for the cell and gene therapy market.

AAPS 2022 Conference Highlights

October 25, 2022

Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Com, discuss cell & gene therapies and co-processed APIs respectively.

Addressing Developmental Challenges of Gene Therapy Viral Vectors

October 16, 2022

Significant improvements have been developed to tackle the challenges in viral vector manufacturing at each stage.

FDA Expands Oversight of Cell and Gene Therapies

October 12, 2022

CBER maps modernization plan to handle surge in research and applications.

Testing for Adventitious Agents in Viral Vector Production

October 05, 2022

Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.

Choosing the Right CDMO for CGT Programs

October 02, 2022

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

Growth in Cell and Gene Therapy Market

October 02, 2022

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Charles River and Cure AP-4 Announce Manufacturing Collaboration

September 09, 2022

Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.

Forecyte Bio and Cytiva to Collaborate on Cell and Gene Therapy Manufacturing and Development

August 31, 2022

Forecyte Bio and Cytiva will team up to accelerate the development and manufacturing of cell and gene therapies.